Compare Neurocrine Biosciences Inc (NBIX) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Paycom Software Inc — how do they compare? Neurocrine Biosciences Inc trades at $152 (market cap $16.46B), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: Neurocrine Biosciences Inc is the larger of the two by market cap, and Paycom Software Inc pays a 0.71% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | PAYC | |
|---|---|---|
Market Cap | $16.46B | $9.57B |
Sector | Health | Technology |
52-Week High | $185.50 | $233.89 |
52-Week Low | $123.10 | $113.59 |
Enterprise Value | $16.48B | $10.35B |
Dividend Yield | — | 0.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
